Magnetar Financial’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $452K | Buy |
+2,064
| New | +$452K | ﹤0.01% | 596 |
|
|
2024
Q4 | – | Sell |
-33,631
| Closed | -$10.1M | – | 806 |
|
|
2024
Q3 | $10.1M | Buy |
33,631
+24,214
| +257% | +$7.27M | 0.22% | 90 |
|
|
2024
Q2 | $3.1M | Buy |
9,417
+5,491
| +140% | +$1.81M | 0.06% | 159 |
|
|
2024
Q1 | $1.55M | Sell |
3,926
-17,005
| -81% | -$6.73M | 0.03% | 222 |
|
|
2023
Q4 | $7.37M | Buy |
20,931
+14,871
| +245% | +$5.24M | 0.19% | 90 |
|
|
2023
Q3 | $2.27M | Buy |
+6,060
| New | +$2.27M | 0.06% | 173 |
|
|
2023
Q2 | – | Sell |
-29,300
| Closed | -$10.2M | – | 628 |
|
|
2023
Q1 | $10.2M | Buy |
+29,300
| New | +$10.2M | 0.2% | 104 |
|
|
2022
Q4 | – | Sell |
-13,983
| Closed | -$3.44M | – | 960 |
|
|
2022
Q3 | $3.44M | Buy |
+13,983
| New | +$3.44M | 0.05% | 442 |
|
|
2020
Q1 | – | Sell |
-2,364
| Closed | -$355K | – | 661 |
|
|
2019
Q4 | $355K | Buy |
+2,364
| New | +$355K | 0.01% | 399 |
|
|
2019
Q2 | – | Sell |
-2,358
| Closed | -$260K | – | 555 |
|
|
2019
Q1 | $260K | Buy |
+2,358
| New | +$260K | 0.01% | 339 |
|
|
2017
Q2 | – | Sell |
-8,802
| Closed | -$718K | – | 957 |
|
|
2017
Q1 | $718K | Buy |
+8,802
| New | +$718K | 0.01% | 383 |
|